Thomas S. Lam
CIK 1664499 · View on SEC EDGAR ↗
First SEC filing: April 29, 2016 · Latest: April 29, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 14, 2020 | ASTH | P | 5,000 | $17.28 | $86,400 | 690,490 Indirect | +0.73% | Acquired | 137.3% (price as of 2026-08-19) |
| Sept. 9, 2020 | ASTH | P | 5,000 | $17.85 | $89,250 | 1,814,872 Indirect | +0.28% | Acquired | 129.7% (price as of 2026-08-19) |
| Aug. 27, 2020 | ASTH | P | 5,000 | $18.23 | $91,150 | 1,776,614 Indirect | +0.28% | Acquired | 124.9% (price as of 2026-08-19) |
| Nov. 14, 2019 | ASTH | P | 10,000 | $14.84 | $148,400 | 1,743,623 Indirect | +0.58% | Acquired | 176.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 8, 2025 | ASTH | Stock Option (right to buy) | Common Stock (29,502) | $17.78 | Dec. 10, 2025 | 29,502 | Disposed |
| Sept. 9, 2024 | ASTH | Stock Option (right to buy) | Common Stock (28,046) | $18.65 | Dec. 30, 2024 | 28,046 | Disposed |
| Dec. 5, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (51,443) | $10.00 | Dec. 8, 2022 | 51,443 | Disposed |
| Dec. 5, 2022 | ASTH | Warrants to purchase Common Stock | Common Stock (48,586) | $11.00 | Dec. 8, 2022 | 48,586 | Disposed |
| March 30, 2021 | ASTH | Warrant to Purchase Common Stock | Common Stock (31,755) | $10.00 | March 30, 2021 | 31,755 | Disposed |
| Dec. 10, 2020 | ASTH | Stock Option (right to buy) | Common Stock (29,502) | $17.78 | Dec. 10, 2025 | 29,502 | Acquired |
| Sept. 8, 2020 | ASTH | Warrants to Purchase Common Stock | Common Stock (63,510) | $9.00 | Oct. 14, 2020 | 63,510 | Disposed |
| Dec. 30, 2019 | ASTH | Stock Option (right to buy) | Common Stock (28,046) | — | Dec. 30, 2024 | 28,046 | Acquired |
| Dec. 27, 2019 | ASTH | Stock Option (right to buy) | Common Stock (39,189) | — | Sept. 30, 2024 | 39,189 | Disposed |
| Sept. 30, 2019 | ASTH | Stock Option (right to buy) | Common Stock (39,189) | — | Sept. 30, 2024 | 39,189 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 29, 2016 | ASTH | Common Stock [F1] | — | Indirect |
| April 29, 2016 | ASTH | Series A Preferred Stock→ Common Stock | — | Indirect |
| Jan. 25, 2016 | ASTH | Common Stock | — | Indirect |
| Jan. 25, 2016 | ASTH | Series A Preferred Stock→ Common Stock | — | Indirect |
| Jan. 25, 2016 | ASTH | Warrants to purchase Common Stock→ Common Stock | — | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ASTH
CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $950,000 | — | $1,878,400 | — | — | — | $14,662 | $2,843,062 |
| 2022 | $950,000 | $450,000 | — | — | — | — | $87,709 | $1,487,709 |
| 2021 | $950,000 | — | $4,661,541 | $1,115,766 | — | — | $129,887 | $6,857,194 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.